Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Capricor Therapeutics
Biotech
FDA reconsidering Capricor’s snubbed DMD cell therapy
The agency has “lifted” the rejection letter for deramiocel, the company said, with a new decision expected by Aug. 22.
Darren Incorvaia
Mar 10, 2026 11:14am
Capricor sets up 2nd DMD approval attempt with ph. 3 win
Dec 3, 2025 11:11am
Capricor responds to cell therapy snub, disputes FDA’s concerns
Sep 9, 2025 11:44am
FDA plans real-time release of drug rejection letters
Sep 4, 2025 1:45pm
FDA rejects Capricor’s DMD cell therapy, asks for more data
Jul 11, 2025 9:18am
BMS oncology head swings to Syndax—Chutes & Ladders
May 16, 2025 8:30am